{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:54:00Z","timestamp":1791154440179,"version":"4.1.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016078","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T21:39:12Z","timestamp":1294954752000},"page":"e16078","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Role of the BMP Signaling Antagonist Noggin in the Development of Prostate Cancer Osteolytic Bone Metastasis"],"prefix":"10.1371","volume":"6","author":[{"given":"Chiara","family":"Secondini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Wetterwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Thalmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco G.","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.","volume":"31","author":"L Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0046-8177(03)00190-4","article-title":"Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone.","volume":"34","author":"MP Roudier","year":"2003","journal-title":"Hum Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.","volume":"10","author":"W Kozlow","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref4","first-page":"317","article-title":"The cost of treating skeletal-related events in patients with prostate cancer.","volume":"14","author":"MJ Lage","year":"2008","journal-title":"Am J Manag Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis.","volume":"350","author":"GD Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis.","volume":"80","author":"GR Mundy","year":"1997","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone.","volume":"5","author":"CJ Logothetis","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/ERC-09-0012","article-title":"Mechanisms of bone metastases of breast cancer.","volume":"16","author":"LJ Suva","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases.","volume":"10","author":"JM Chirgwin","year":"2000","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"ref10","first-page":"374","article-title":"Metastastic solid tumors to bone.","author":"GR Mundy","year":"2008"},{"key":"ref11","article-title":"Targeting the bone microenvironment in multiple myeloma.","author":"GD Roodman","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/bjc.1986.136","article-title":"Importance of quantitative histology of bone changes in monoclonal gammopathy.","volume":"53","author":"R Bataille","year":"1986","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb00046.x","article-title":"Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption.","volume":"49","author":"T Taube","year":"1992","journal-title":"Eur J Haematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.","volume":"42","author":"YW Qiang","year":"2008","journal-title":"Bone"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2008-01-132134","article-title":"Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.","volume":"112","author":"YW Qiang","year":"2008","journal-title":"Blood"},{"key":"ref16","first-page":"6","article-title":"Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma.","volume":"83","author":"DJ Heath","year":"2008","journal-title":"Calcified Tissue International"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2353\/ajpath.2007.051276","article-title":"Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.","volume":"170","author":"R Schwaninger","year":"2007","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0002-9440(10)64934-6","article-title":"Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.","volume":"160","author":"A Wetterwald","year":"2002","journal-title":"Am J Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.gt.3302801","article-title":"T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.","volume":"13","author":"CH Swan","year":"2006","journal-title":"Gene Ther"},{"key":"ref20","first-page":"111","article-title":"Noggin arrests stromal cell differentiation in vitro.","volume":"32","author":"E Gazzerro","year":"2003","journal-title":"Bone"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/8756-3282(95)80009-F","article-title":"Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice.","volume":"16","author":"KT Sundquist","year":"1995","journal-title":"Bone"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone Histomorphometry - Standardization of Nomenclature, Symbols, and Units.","volume":"2","author":"AM Parfitt","year":"1987","journal-title":"Journal of Bone and Mineral Research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI3459","article-title":"Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.","volume":"102","author":"E Gazzerro","year":"1998","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-04-2251","article-title":"Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.","volume":"64","author":"DR Haudenschild","year":"2004","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.","volume":"98","author":"TA Guise","year":"1996","journal-title":"Journal of Clinical Investigation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.","volume":"103","author":"JJ Yin","year":"1999","journal-title":"Journal of Clinical Investigation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.","volume":"98","author":"RN Pearse","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.","volume":"33","author":"MS Bendre","year":"2003","journal-title":"Bone"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jcb.22322","article-title":"Growth factor control of bone mass.","volume":"108","author":"E Canalis","year":"2009","journal-title":"J Cell Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.","volume":"349","author":"E Tian","year":"2003","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1210\/me.2006-0346","article-title":"Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation.","volume":"21","author":"GA Clines","year":"2007","journal-title":"Molecular Endocrinology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2.","volume":"106","author":"T Oshima","year":"2005","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","article-title":"Histomorphometric Evidence for Osteoclast-Mediated Bone-Resorption in Metastatic Breast-Cancer.","volume":"15","author":"T Taube","year":"1994","journal-title":"Bone"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S8756-3282(02)00847-5","article-title":"Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma.","volume":"31","author":"S Vukmirovic-Popovic","year":"2002","journal-title":"Bone"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/BF00710766","article-title":"Histomorphometric Analysis of Osteoclastic Bone-Resorption in Metastatic Bone-Disease from Various Primary Malignomas.","volume":"409","author":"HA Kulenkampff","year":"1986","journal-title":"Virchows Archiv a-Pathological Anatomy and Histopathology"},{"key":"ref36","first-page":"1","article-title":"Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.","volume":"5","author":"A Parfitt","year":"1995","journal-title":"The Canadian journal of oncology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jcb.10746","article-title":"Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation.","volume":"91","author":"AM Mastro","year":"2004","journal-title":"Journal of Cellular Biochemistry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10585-004-1867-6","article-title":"Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.","volume":"21","author":"RR Mercer","year":"2004","journal-title":"Clinical & Experimental Metastasis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pros.21075","article-title":"The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.","volume":"70","author":"C Morrissey","year":"2010","journal-title":"Prostate"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1126\/science.280.5368.1455","article-title":"Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton.","volume":"280","author":"LJ Brunet","year":"1998","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/en.2002-220918","article-title":"Skeletal overexpression of noggin results in osteopenia and reduced bone formation.","volume":"144","author":"RD Devlin","year":"2003","journal-title":"Endocrinology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI15543","article-title":"Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.","volume":"112","author":"XB Wu","year":"2003","journal-title":"J Clin Invest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00191214","article-title":"Bone morphogenetic protein-6 expression in normal and malignant prostate.","volume":"13","author":"J Barnes","year":"1995","journal-title":"World J Urol"},{"key":"ref44","first-page":"4427","article-title":"Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.","volume":"57","author":"FC Hamdy","year":"1997","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1158\/0008-5472.CAN-05-1891","article-title":"Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.","volume":"65","author":"J Dai","year":"2005","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jcb.20735","article-title":"Role of Wnts in prostate cancer bone metastases.","volume":"97","author":"CL Hall","year":"2006","journal-title":"J Cell Biochem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/pros.2990240406","article-title":"Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.","volume":"24","author":"SE Harris","year":"1994","journal-title":"Prostate"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10585-007-9118-2","article-title":"TGF-beta and BMP7 interactions in tumour progression and bone metastasis.","volume":"24","author":"JT Buijs","year":"2007","journal-title":"Clin Exp Metastasis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2353\/ajpath.2007.070168","article-title":"BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo.","volume":"171","author":"JT Buijs","year":"2007","journal-title":"Am J Pathol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/07357908909017529","article-title":"Osteocalcin as a biological marker in the therapeutic management of breast cancer bone metastases.","volume":"7","author":"B Neri","year":"1989","journal-title":"Cancer Invest"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1182\/blood-2006-09-047712","article-title":"Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.","volume":"109","author":"S Yaccoby","year":"2007","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.081104","article-title":"Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma.","volume":"24","author":"DJ Heath","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ijc.23625","article-title":"Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.","volume":"123","author":"G Bu","year":"2008","journal-title":"Int J Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through Wnts.","volume":"65","author":"CL Hall","year":"2005","journal-title":"Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.bjc.6603959","article-title":"Increased Dickkopf-1 expression in breast cancer bone metastases.","volume":"97","author":"N Voorzanger-Rousselot","year":"2007","journal-title":"Br J Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tcb.2006.01.001","article-title":"A Wnt canon orchestrating osteoblastogenesis.","volume":"16","author":"C Hartmann","year":"2006","journal-title":"Trends in Cell Biology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/0008-5472.CAN-07-6541","article-title":"Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms.","volume":"68","author":"JL Dai","year":"2008","journal-title":"Cancer Research"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e4092","DOI":"10.1371\/journal.pone.0004092","article-title":"Lrp4 modulates extracellular integration of cell signaling pathways in development.","volume":"3","author":"A Ohazama","year":"2008","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"23159","DOI":"10.1074\/jbc.M109.025478","article-title":"Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals.","volume":"284","author":"KB Lintern","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","article-title":"Therapeutic Potential of Adult Bone Marrow-Derived Mesenchymal Stem Cells in Prostate Cancer Bone Metastasis.","volume":"15","author":"D Chanda","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1158\/0008-5472.CAN-04-4188","article-title":"Interference with the microenvironmental support impairs the de novo formation of bone metastases in vivo.","volume":"65","author":"G van der Pluijm","year":"2005","journal-title":"Cancer Research"},{"key":"ref62","first-page":"3551","article-title":"Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.","volume":"55","author":"A Sasaki","year":"1995","journal-title":"Cancer Res"},{"key":"ref63","first-page":"192","article-title":"Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.","volume":"91","author":"S Yaccoby","year":"2006","journal-title":"Haematologica-the Hematology Journal"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2005.07.015","article-title":"Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.","volume":"38","author":"BT Feeley","year":"2006","journal-title":"Bone"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","article-title":"The RANK\/RANKL\/OPG triad in cancer-induced bone diseases.","volume":"25","author":"WC Dougall","year":"2006","journal-title":"Cancer and Metastasis Reviews"},{"key":"ref66","article-title":"Targeting RANK\/RANKL in the Treatment of Solid Tumours and Myeloma.","author":"CH Buckle","year":"2010","journal-title":"Curr Pharm Des"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T10:07:58Z","timestamp":1637143678000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016078"}},"subtitle":[],"editor":[{"given":"Chad","family":"Creighton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016078","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}